Quick Answer
Cabaletta Bio, Inc. reported Shares Outstanding of 100.48 million shares for fiscal year 2025.
Cabaletta Bio, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 100.48M | +98.0% |
| 2024 | 50.74M | +6.1% |
| 2023 | 47.82M | +62.4% |
| 2022 | 29.45M | +1.8% |
| 2021 | 28.93M | +20.2% |
| 2020 | 24.06M | +0.1% |
| 2019 | 24.03M | +524.5% |
| 2018 | 3.85M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 96.27M | +97.1% | +5.3% |
| June 30, 2025 | 91.45M | +89.4% | +80.2% |
| December 31, 2024 | 50.74M | +6.1% | +3.9% |
| September 30, 2024 | 48.85M | +17.3% | +1.2% |
| June 30, 2024 | 48.29M | +21.4% | +0.1% |
| March 31, 2024 | 48.25M | +53.9% | +0.9% |
| December 31, 2023 | 47.82M | +62.4% | +14.8% |
| September 30, 2023 | 41.66M | +43.6% | +4.7% |
- Cabaletta Bio, Inc. showed an increase of +98.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2018–2025 period, Cabaletta Bio, Inc.’s shares outstanding has grown by 2511.0% (from 3.85 million shares to 100.48 million shares).
- The most recent figure is from Cabaletta Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: